Matthew Mitchell, MD
Anesthesiology · Lafayette, LANPI 1780671842
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,517 of the $4,523 with a category attached, or 77.8%. Abbott accounts for 60.0% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2020 at $1,845 and has fallen 80.5% since, to $359 in 2025. Among anesthesiology clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 131 payments — averaging $34.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Medtronic$408
- Nevro Corp.$273
- Boston Scientific$230
- Pacira Pharmaceuticals Incorporated$217
- Saluda Medical Americas, Inc.$128
- plus $551 from 18 others
What the payments were for
- Travel & lodging$1,00622%
- Food & beverage$3,51778%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 61 | $2,716 |
| Medtronic(2 entities) | 27 | $408 |
| Nevro Corp. | 9 | $273 |
| Boston Scientific | 4 | $230 |
| Pacira Pharmaceuticals Incorporated | 2 | $217 |
| Saluda Medical Americas, Inc. | 2 | $128 |
| Biotronik NRO, Inc. | 2 | $122 |
| Globus Medical | 2 | $50 |
| IBSA Pharma Inc. | 2 | $41 |
| Spinal Simplicity, LLC | 2 | $39 |
| Assertio Therapeutics, Inc. | 3 | $37 |
| Valinor Pharma, LLC | 2 | $35 |
| Acacia Pharma Inc | 2 | $33 |
| Averitas Pharma Inc. | 1 | $24 |
| GRT US Holding, Inc. | 1 | $24 |
| Redhill Biopharma Inc. | 1 | $22 |
| Almatica Pharma LLC | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Stryker | 1 | $17 |
| Merz North America, Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Stimwave Technologies Incorporated | 1 | $13 |
| Si-bone, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Proclaim IPG$861
- Proclaim Family of SCS IPGs$417
- ETERNA$141
- Intracept$129
- EXPAREL$122
- Senza Spinal Cord Stimulation System$111
- Evoke$103
How this compares
$4,523 in reported general payments places this provider in the 95th percentile of 497 anesthesiology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,409 | $31,611 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 799 | $24,198 |
| BelbucaBuprenorphine Hcl | 21 | $20,218 |
| MovantikNaloxegol Oxalate | 37 | $14,917 |
| Tizanidine Hcl | 658 | $10,212 |
| Gabapentin | 788 | $9,874 |
| Pregabalin | 387 | $9,464 |
| OxycontinOxycodone Hcl | 11 | $5,302 |
| Fentanyl | 33 | $5,080 |
| Baclofen | 365 | $3,362 |
| Duloxetine Hcl | 296 | $3,157 |
| Oxycodone Hcl | 117 | $2,740 |
| Celecoxib | 151 | $2,415 |
| Lidocaine | 27 | $1,998 |
| Methadone Hcl | 115 | $1,764 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $17 | $20,21821 claims |
| Redhill Biopharma Inc.Movantik | $22 | $14,91737 claims |
| Almatica Pharma LLCSertraline Hcl | $18 | $6721 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 497 anesthesiology providers in Louisiana.
Other anesthesiology in Lafayette
- Danielle BabbLafayette$3K
- Amarendar KasarlaLafayette$2K
- William DedoLafayette$2K
- Sanjiv JindiaLafayette$816
- Keith MayfieldShreveport$32K
- John GuilliotNew Orleans$32K
- Brian CrenshawBenton$26K
- Caroline CarrollShreveport$26K
- Aya MouhaffelShreveport$20K
- Richard FairShreveport$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.